Patents by Inventor Daniela Krause

Daniela Krause has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190374618
    Abstract: The present invention pertains to fibronectin or Integrin-linked Kinase (ILK) inhibitors/antagonists in the treatment of imatinib resistant leukemia. The invention relates to the use of recombinant or isolated fibronectin or an ILK inhibitor as adjuvant therapy during leukemia treatment, either as single ingredient medicament or in a combination therapy, preferably with ABL inhibitors such as imatinib or nilotinib.
    Type: Application
    Filed: September 8, 2017
    Publication date: December 12, 2019
    Inventors: Daniela Krause, Melanie Meister, Rahul Kumar